archTIS (ASX:AR9 / OTCQB:ARHLF / WKN A3CWKA)

Do your own research. I probably have made mistakes. # archTIS (ASX:AR9 / WKN A3CWKA) # 1) What archTIS is archTIS positions itself as a data-centric security vendor focused on secure collaboration for sensitive/classified information. Its product set centers on policy enforcement (e.g., attribute-based access controls) across Microsoft environments and regulated workflows. Key products include NC Protect, Kojensi, Trusted Data Integration, and (since late 2025) Spirion for data discovery/classification/remediation. # 2) Recent events timeline |Date|Event|Why it matters| |:-|:-|:-| || |16 Jun 2025|Initial U.S. DoD milestone: NC Protect licence award for 1,000 users, A$38,500 (6 months), via a prime contractor; company messaging framed this as an entry point with potential to scale if later phases expand.|Small dollars, big signal: validation + procurement pathway + DoD365 relevance.| |8 Jul 2025|Completed A$7.5M capital raise (shares issued at A$0.15).|Extra runway for U.S. growth, partnerships, and product work.| |30 Sep–2 Oct 2025|Spirion acquisition disclosed/covered: Spirion described as having 150+ enterprise customers and a U.S.-based team joining archTIS.|Step-change in U.S. presence and capability (data discovery/classification complements policy enforcement).| |1 Oct 2025|Spirion acquisition completion widely reported.|Integration phase begins; cross-sell and ARR expansion narrative becomes central.| |17 Oct 2025|Additional U.S. DoD services contract: A$250,000 customised development work (via partner channel), due by 16 Jan 2026.|Paid “implementation + tailoring” deepens embed; delivery date becomes a near-term catalyst.| |31 Oct 2025|Quarterly update (Sep 2025 quarter): highlighted mix shift toward licensing, strong gross margin, and post-acquisition ARR uplift; also flagged U.S. procurement delays linked to shutdown impacts.|Numbers frame for the Spirion step-change; also a real execution risk (timing).| |3 Nov 2025|NC Protect for Microsoft 365 Version 9 released with deeper Microsoft security ecosystem integrations (Purview/Entra ID/Defender) and Spirion linkage.|Product maturation aimed at regulated environments and larger deployments.| |22 Dec 2025|DoD365 progression + renewal + funding: reported move into a production environment and renewal of 1,000 licences; also referenced a non-dilutive A$8M drawdown debt facility to support integration/expansion.|“Production” is a meaningful milestone; debt facility reduces near-term dilution but adds leverage considerations.| # 3) The core investment narrative # A) The U.S. DoD365 wedge: small revenue, potentially large pathway The initial 1,000-seat licence is economically small, but strategically it’s about moving from evaluation to production use and then into larger seat blocks. Bulls see this as a credible wedge into highly controlled environments where getting operational acceptance matters more than the first cheque. Bear counterpoint: even after production, scaling can still stall due to budget cycles, procurement timing, and internal prioritization inside government programs. # B) Spirion: the “scale + cross-sell” lever Spirion is meant to add: * broader North American footprint and enterprise customer base * larger U.S. operating presence (people and go-to-market reach) * complementary capability (data discovery/classification/remediation) Strategically, the combined story becomes: discover/classify sensitive data (Spirion) + enforce access and collaboration controls in Microsoft 365 (NC Protect). That creates a “platform” pitch rather than a single-feature pitch. Execution risk: integration (product, sales motion, retention) and whether cross-sell is real versus theoretical. # C) Product posture: leaning into Microsoft security stack NC Protect V9 emphasized tighter integration with Microsoft security and identity tooling and more enterprise-grade deployment/administration features. This aligns with the thesis that Microsoft 365 is the collaboration layer, and archTIS is an enforcement layer for regulated and high-sensitivity use cases. # 4) Operating/financial framing From the Sep 2025 quarter messaging and subsequent updates, the company emphasized: * mix shifting toward licensing (higher quality recurring revenue profile) * strong gross margin profile * an ARR uplift after adding Spirion * additional funding capacity via a non-dilutive drawdown facility (but with debt trade-offs) This sets up 2026 as an execution year: prove retention and cross-sell, prove DoD/regulated expansion, and prove the combined ARR can grow without constant dilution. # 5) Near-term watchlist 1. Delivery and outcomes from the A$250k DoD-related development work (due mid-Jan 2026) and whether it leads to follow-on licence expansion. 2. Any confirmation of seat expansion beyond the initial 1,000 DoD licences (the market will watch for tranche size and pace). 3. Spirion integration evidence: churn/retention commentary, unified packaging, and actual cross-sell wins (not just “pipeline”). 4. Any clearer signals on procurement normalization after prior delays. # 6) Risks * Procurement timing and political/budget noise can create long gaps between “milestones” and meaningful revenue. * Narrative concentration: if the bull thesis relies heavily on a single DoD scaling event, volatility rises when timelines slip. * Integration risk: merging Spirion into a smaller listed entity can distract execution and slow product/sales focus. * Debt facility trade-off: less dilution now, but repayment/terms matter if growth lags. Do your own research. This is not a financial advice. PS. Reddit filter forced me to abandon all links and sources.